Sibiriline(Seabelife)

N/A

Report date: 2024/09/24 16:59:33
NME

Base Information

Drug NameSibiriline(Seabelife)
Drug Alias NameSBL-1SBL-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeaBeLife Biotech
China Registration ClassN/A

Develop Information

Active CompaniesSeaBeLife Biotech
Inactive CompaniesN/A
Active IndicationsHepatic Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A